Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06142903
Other study ID # 850914
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2022
Est. completion date December 31, 2024

Study information

Verified date November 2023
Source University of Pennsylvania
Contact Charlene Compher, PhD
Phone 12672316273
Email compherc@upenn.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This protocol is designed to compare the effectiveness of two dietary intervention doses for patients with heart failure (HF) and malnutrition risk or malnutrition at hospital discharge. This random order crossover design will provide evidence as to whether the provision of dinner meals alone versus all 3 daily meals to patients' homes is more effective at improving malnutrition risk score, and secondarily unplanned emergency department visits and readmissions.


Description:

1.1 Background and Relevant Literature Heart failure (HF) is a common clinical syndrome occurring in 6.2 million adults in the US with a cost of $30.7 million in 2012 due to health care services, medications, and missed days of work. The symptoms of HF result from the impaired ability of the heart to deliver blood and oxygen adequately to peripheral tissues. Patients with HF at the Hospital of the University of Pennsylvania experience worse than expected clinical outcomes. Length of hospital stay in FY2021 (mean LOS 7.49 d, expected LOS 6.6 d) and FY22 (mean 7.21 d, expected 6.6 d), and 30-day readmissions were 17.1% in FY21 and 17.3% in FY22. Malnutrition is a common comorbid condition with HF. In an observation of 4000 patients with HF, 57% had at least mild malnutrition, a condition that was associated with increased mortality. The malnutrition reported with HF comprises protein-energy malnutrition, muscle wasting, and cachexia, variables evaluated during malnutrition assessment. Patients with malnutrition have worse clinical outcomes. Patients at our hospital who had moderate or severe disease-related malnutrition during the hospital stay had significantly more 30-day readmissions (40% versus 23%, OR 2.13, 1.82-2.48), greater mortality (OR 1.47, 1.0-1.99), and longer length of stay (15 vs 12 days, p= 0.0067) than patients who did not meet criteria for malnutrition4. In data from the 2012-2014 Nationwide Inpatient Sample, malnutrition was associated with mortality OR of 2.48, 2.3-2.66, almost double the admission cost, and longer length of stay of 8.7 days, 8.5-8.6 vs 5.3, 5.2-5.35. The mainstay of HF disease management is patient self-management of medications, diet (restriction of Na with limited alcohol and fluid restriction to 1.5-2 L daily). Daily self-weighing is a strategy to detect fluid accumulation and permit adjustment of fluid intake or medical therapy. In addition to a Na restriction, the Diet Approach to Stop Hypertension or Mediterranean diet has been suggested. To optimize cardiovascular health and reduce cardiac deaths and strokes by 20%, the 2020 American Heart Association (AHA) guidelines included an evidence-based dietary approach targeting servings of six food groups (optimal intake of whole grains, fruits/vegetables, nuts/seeds/legumes, and fish; with limited intake of processed meats and sweet beverages)8 and with restriction of sodium intake to < 1500 mg and saturated fat to <7% of kcal. The DASH diet approach emphasizes intake of fruits, vegetables, whole grains, dairy, nuts/seeds/legumes, and limits intake of meat, sweets, and fats. A six-month nutrition intervention that included oral nutrition supplements in malnourished patients with HF significantly reduced mortality. While readmissions in patients with HF are generally attributed to disease exacerbations, the disease exacerbations may be related to diet. Patients with HF should follow a strict Na-restricted heart healthy diet as a strategy to limit fluid accumulation that can exacerbate symptoms of edema, bloating and dyspnea. However, disease-related symptoms of fatigue or dyspnea may make preparing such a diet challenging because meals must be prepared without the use of processed or commercial frozen food items due to their high sodium and fat content. Clinicians often treat patients with HF in the ED during emergency department visits (EDV) to avoid formal hospital admissions, though data on this outcome are not commonly reported. However, EDVs are disruptive to the quality of life of the patient and utilize hospital resources. We hypothesize that reducing malnutrition risk by providing medically-tailored meals may provide protection against 30-day unplanned readmissions and EDV. Simple interventions such as provision of medically-tailored meals to the patient's home setting hold the potential to improve malnutrition and prevent both EDV and readmissions. One pilot trial compared 21 meals/week to standard care in patients with HF, with a trend towards fewer readmissions in the meals treatment arm. A small pilot in elderly patients, 38% of whom were diagnosed with HF, determined that it was feasible to provide 10 days of home-delivered meals, but lacked statistical power to determine the impact on readmissions by 45 days. However, there are no data to determine whether dinner meals alone will provide equivalent outcomes to 21 meals/week, or whether provision of medically tailored meals can improve malnutrition risk or reduce EDVs or readmissions. 2 Study Objectives The overall objective of the study is to determine whether the provision of 7 or 21 medically tailored meals per week to the patient in their home setting can improve malnutrition risk (MST score), and secondarily reduce 30-day unplanned EDV, readmissions, and improve diet quality by PDH score. 2.1 Primary Objective • To compare the effectiveness of home delivery of 7 versus 21 medically-tailored meals per week on improvement (reduction) in malnutrition risk (MST score). 2.2 Secondary Objectives • To compare the effectiveness of home delivery of 7 versus 21 medically-tailored meals per week on unplanned 30-day EDV or readmissions and PHD score. 3 Investigational Plan Patients with HF who are identified with moderate or severe malnutrition during their HUP admission will be offered participation in the random order crossover design home-based feeding trial. Telephone visits with the patient at day 0±5, 30±5 and 60±5 will be used to gather MST, PHD, SARC-F, calf circumference, and weight data. The meals will be delivered weekly to the patient's home address by MANNA. The EDV and readmission outcomes will be adjudicated by the clinical dietitian in consultation with the cardiology medical team, as planned or unplanned events. Adverse events will be adjudicated for seriousness and relatedness to the diet intervention by Dr Bruce Kinosian, the study's safety officer. 3.1 General Design Consented patients will be randomized using a computer-generated scheme to delivery of either 7 dinner meals or 21 meals (7 breakfast, 7 lunch, 7 dinner meals) each week for 4 weeks duration. At approximately day 0, 30 and 60 relative to discharge from the hospital, patients will be contacted by telephone to assess their MST score, diet quality relative to AHA dietary goals, and obtain their self-measured weight and calf circumference. 3.2 Allocation to Interventional Group Subjects will be randomized in a one to one fashion to the order of 7 versus 21 meals/week intervention for one month followed immediately by the other treatment arm, using a computer-generated algorithm designed by the study statistician. MANNA contacts will be aware of the treatment arm assignment, but the study personnel will be blinded. Because the study meals are provided using the same foods, a washout period is not indicated. 3.3 Study Measures Each of the following tools will be collected by telephone contact with enrolled patients at approximately 0, 30 and 60 days relative to hospital discharge. The Malnutrition Screening Tool (MST) score ranges from 0-5, with higher scores indicating greater risk of malnutrition. The Penn Healthy Diet Survey (PHD) score ranges 0-64, with higher scores indicating a healthier diet. Sarcopenia Screening Tool (SARC-F) score ranges 0-10 with higher results indicating greater debility. Calf Circumference will be measured in cm by the patient or a caregiver at the maximum diameter of the calf using a paper measuring tape provided by the study prior to discharge. Weight measured on the day of the telephone call will be recorded. Adherence to medically-tailored meals will be determined by asking the patient how many of the meal entrees they were able to consume in the prior week.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date December 31, 2024
Est. primary completion date July 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Age = 18 - Diagnosis of Heart Failure (NYHA Class 1-3/ ACC/AHA Stage C) and moderate or severe malnutrition or malnutrition risk - Residence within MANNA delivery area Exclusion Criteria: 1. >90 years of age 2. Dementia/cognitive decline 3. Heart Failure stage 4 or D 4. Chronic kidney disease stage 5 or dialysis-dependent (GFR<30 mL/min/1.72 m2) 5. Unstable COPD as COPD flare within prior 3 months 6. Active cancer therapy 7. Pregnancy 8. Living in a residential facility such as prison, long-term care, rehabilitation, other 9. Allergy to foods on the menus 10. Persistent hyperkalemia (> 5 mEq/L) more than twice without excess potassium intake during hospital admission 11. Persistent hypotension (systolic BP<100 mm Hg) during the hospital admission 12. Systolic BP> 180 or diastolic BP >100 mmHg 13. Active substance or alcohol abuse

Study Design


Related Conditions & MeSH terms


Intervention

Other:
7 versus 21 medically tailored meals per week
Meals designed to support overall cardiovascular health will be provided to patients in their own home setting.

Locations

Country Name City State
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

References & Publications (1)

Compher CW, Quinn R, Haslam R, Bader E, Weaver J, Dudek S, Ritchie MD, Lewis JD, Wu GD. Penn Healthy Diet survey: pilot validation and scoring. Br J Nutr. 2023 Jul 31:1-7. doi: 10.1017/S0007114523001642. Online ahead of print. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary change in malnutrition risk Malnutrition risk will be measured by the Malnutrition Risk Score survey one month
Secondary Emergency Department Visits ED visits will be evaluated relative to likelihood of dietary vs disease influence one month
Secondary Readmissions within 30 days Readmissions during each 30-day window of diet treatment arm will be evaluated relative to the influence of diet versus disease one month
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy